Search
for
Sort by
Research 361–390 of 1000+
- Clinical Management in Psychodermatology
- National scientific medical meeting 1996 abstracts
- Cytostatics and immunosuppressive drugs
- Stem Cell-Based Tissue Engineering for the Treatment of Burn Wounds: A Systematic Review of Preclinical Studies
- Hirsutism
- APPLICATION OF ACELLULAR GRAFTS FOR EXTENSIVE SKIN DEFECTS – A REVIEW
- Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
- Measurement of tamsulosin in human serum by liquid chromatography–tandem mass spectrometry
- Global research trends in non-muscle invasive bladder cancer: Bibliometric and visualized analysis
- Hormonal manipulation of benign prostatic hyperplasia
- Pharmacological Effects of the Lipidosterolic Extract from Kigelia africana Fruits in Experimental Benign Prostatic Hyperplasia Induced by Testosterone in Sprague Dawley Rats
- Low-dose finasteride in benign prostatic hyperplasia: a comprehensive narrative review of efficacy, safety, and preventative potential
- 5 Alpha-reductase inhibitors: whatʼs new?
- Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia
- Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States
- HPLC characterization, molecular docking, QSAR and molecular dynamics simulation of Alstonia boonei phytochemical analogs as potent 5-alpha reductase inhibitors
- Finasteride versus dutasteride: a real-world economic evaluation.
- Psychiatric and sexual dysfunction warnings strengthened for finasteride and dutasteride
- Clinics in diagnostic imaging (221)
- Viola odorata L.
- 5ARI and PSA: open questions
- “Peeling paint” dermatosis in a leukemia patient
- Development of validated methods for the simultaneous quantification of Finasteride and Tadalafil in newly launched FDA-approved therapeutic combination: greenness assessment using AGP, analytical eco-scale, and GAPI tools
- The effect of 5-α reductase inhibitor on Th1, Th2, and Th17 cell-related inflammatory response in BPH
- Risks and side effects in the medical management of benign prostatic hyperplasia
- The post-finasteride syndrome: possible etiological mechanisms and symptoms
- High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Effects of mitotane treatment on human steroid metabolism: implications for patient management
- Functionalised-biomatrix for wound healing and cutaneous regeneration: future impactful medical products in clinical translation and precision medicine
- Aesthetically relevant symptoms of menopause transition: Impact and approach to management